Quizartinib (AC220) is a potent second generation class III tyrosine kinase inhibitor that displays a distinct inhibition profile against mutant-FLT3, -PDGFRA and -KIT isoforms
Kerstin Maria Kampa-Schittenhelm(University of St.Gallen), Marcus M. Schittenhelm(OST - Ostschweizer Fachhochschule)
Cited by 121